Verastem Oncology
VSTM
#6555
Rank
ยฃ0.60 B
Marketcap
ยฃ4.84
Share price
-7.73%
Change (1 day)
-31.70%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2026 (TTM): -ยฃ0.16 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are ยฃ87.52 Million. In 2025 the company made an earning of -ยฃ0.17 Billion a decrease over its 2024 earnings that were of -ยฃ99.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ0.16 Billion-5.76%
2025 -ยฃ0.17 Billion60.57%
2024 -ยฃ99.73 Million49.31%
2023 -ยฃ66.79 Million18.36%
2022 -ยฃ56.43 Million3.67%
2021 -ยฃ54.43 Million5.43%
2020 -ยฃ51.63 Million-54.74%
2019 -ยฃ0.12 Billion105.99%
2018 -ยฃ55.37 Million6.83%
2017 -ยฃ51.83 Million86.06%
2016 -ยฃ27.86 Million-37.03%
2015 -ยฃ44.24 Million8.43%
2014 -ยฃ40.8 Million29.52%
2013 -ยฃ31.5 Million28.6%
2012 -ยฃ24.5 Million133.9%
2011 -ยฃ10.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ5.32 B-3,551.52%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ1.11 B-820.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ5.46 B-3,643.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-ยฃ6.46 Million-95.82%๐Ÿ‡บ๐Ÿ‡ธ USA